Quantcast
Channel: cafepharma - Valeant Pharmaceuticals
Browsing all 157 articles
Browse latest View live

Endo To Become The Next Valeant - Or Part Of Valeant

Endo To Become The Next Valeant - Or Part Of Valeant Seeking Alpha

View Article


Valeant Earnings Seen Rising As Firm Digests Medicis

Valeant Earnings Seen Rising As Firm Digests Medicis Investors.com

View Article


New CEO From Valeant May Mean Endo Takeover Imminent

New CEO From Valeant May Mean Endo Takeover Imminent Seeking Alpha

View Article

Valeant Buying Obagi Medical; Both Stocks Jump By AMY REEVES, INVESTOR'S...

Valeant Buying Obagi Medical; Both Stocks Jump Investors.com

View Article

Valeant Pharmaceuticals Receives “Buy” Rating from Jefferies Group (VRX)

Valeant Pharmaceuticals Receives “Buy” Rating from Jefferies Group (VRX) Zolmax

View Article


Obagi Medical Sued by Investor Over $360 Million Offer

Obagi Medical Sued by Investor Over $360 Million Offer Bloomberg

View Article

Obagi Medical gets higher offer from Merz Pharma

Obagi Medical gets higher offer from Merz Pharma Reuters

View Article

Most Profitable Second Quarter Biotech Stocks

Most Profitable Second Quarter Biotech Stocks TheStreet.com

View Article


Valeant sweetens bid for Obagi Medical

Valeant sweetens bid for Obagi Medical Reuters

View Article


Obagi Bidding War Seen Pushing Premium to 99%: Real M&A

Obagi Bidding War Seen Pushing Premium to 99%: Real M&A Bloomberg

View Article

Obagi Bidding War Seen Pushing Premium to 99%: Real M&A

Obagi Bidding War Seen Pushing Premium to 99%: Real M&A Bloomberg

View Article

Merz Pharma drops out of race for Obagi Medical

Merz Pharma drops out of race for Obagi Medical Reuters

View Article

Mylan rains on Valeant parade with Zovirax generic

Mylan rains on Valeant parade with Zovirax generic Fierce Pharma

View Article


Valeant, Actavis team up on two more authorized generics

Valeant, Actavis team up on two more authorized generics Fierce Pharma

View Article

Actavis agrees with Valeant's subsidiary to introduce generic versions of...

Actavis agrees with Valeant's subsidiary to introduce generic versions of Ziana, Zyclara Pharmabiz

View Article


4 Stocks Pushing The Drugs Industry Downward

4 Stocks Pushing The Drugs Industry Downward TheStreet.com

View Article

Valeant completes tender offer for Obagi Medical

Valeant completes tender offer for Obagi Medical Yahoo/Fly on the Wall

View Article


Valeant Pharmaceuticals in Talks to Buy Actavis

Valeant Pharmaceuticals in Talks to Buy Actavis Wall Street Journal

View Article

On verge of $13B merger, Valeant and Actavis stop talking

On verge of $13B merger, Valeant and Actavis stop talking Fierce Pharma

View Article

2013 FDA Drug Approval Calendar

2013 FDA Drug Approval Calendar TheStreet.com

View Article
Browsing all 157 articles
Browse latest View live